OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB16272Orelabrutinib4Recruiting1
DB00073Rituximab4Recruiting1